Chiara Dal Pra
University of Padua
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Chiara Dal Pra.
Clinical Endocrinology | 2004
Massimo Tonacchera; Eleonora Ferrarini; Antonio Dimida; Patrizia Agretti; Giuseppina De Marco; Melissa De Servi; Elena Gianetti; Luca Chiovato; Enrico Pucci; Chiara Dal Pra; Corrado Betterle; F. Aghini-Lombardi; Paolo Vitti; Aldo Pinchera
background Premature ovarian failure (POF) is defined by cessation of ovarian function after puberty and before the age of 40. The syndrome is characterized by amenorrhoea, oestrogen deficiency and elevated levels of gonadotrophins. Autoimmunity has been proposed as a mechanism for some cases of destruction or malfunction of ovarian follicles. POF is often associated with type I and type II polyglandular autoimmune syndromes. It has also been postulated that receptors such as the LH and FSH receptors might become targets for blocking antibodies and such antibodies could be a cause of ovarian failure.
European Journal of Clinical Investigation | 2012
Anna Maria Lombardi; Roberto Fabris; Alessandro Scarda; Veronica Zanato; Chiara Dal Pra; Pamela Scarparo; Silvia Vettore; Marnie Granzotto; Giulia Berti de Marinis; Mirto Foletto; Roberto Serra; Maria Teresa Sartori; Mario Plebani; Fabrizio Fabris; Roberto Vettor
Eur J Clin Invest 2012; 42 (11): 1197–1204
Endocrine | 2017
Veronica Zanato; Anna Maria Lombardi; Luca Busetto; Chiara Dal Pra; Mirto Foletto; Luca Prevedello; Giulia Berti de Marinis; Fabrizio Fabris; Roberto Vettor; Roberto Fabris
Obese patients have been described at increased risk of thrombotic thrombocytopenic purpura, a disease caused by anti-ADAMTS13 autoantibodies. ADAMTS13 has a structure homology with the adipokine thrombospondin-1. We previously demonstrated an increased presence of anti-ADAMTS13 antibodies in obese patients. We aimed to study the changes induced by weight loss after bariatric surgery on some inflammatory and coagulative parameters and their link with anti-ADAMTS13 autoantibodies. We studied 100 obese patients before and after weight loss induced by bariatric surgery and 79 lean volunteers as controls. We measured anthropometric, metabolic and inflammatory parameters, thrombospondin-1, ADAMTS13 activity, anti-ADAMTS13 autoantibodies, Von Willebrand factor. At baseline, 13 % of patients was positive for anti-ADAMTS13 autoantibodies, while all controls were negative. Thrombospondin-1 levels were higher in obese subjects with than without antibodies, with a positive correlation between the two parameters. In multiple logistic regression analysis only thrombospondin-1 levels predicted positivity for anti-ADAMTS13 antibodies. After weight loss both anti-ADAMTS13 antibodies and thrombospondin-1 reduced significantly. Weight loss in obesity improves the inflammatory and coagulative profile, and in particular anti-ADAMTS13 autoantibodies, ADAMTS13 activity and thrombospondin-1.
Clinical Lipidology | 2009
Marta Sanna; Chiara Franzin; Michela Pozzobon; Francesca Favaretto; Carlo Alberto Rossi; Alessandra Calcagno; Alessandro Scarda; Chiara Dal Pra; Catia Pilon; Gabriella Milan; Giovanni Federspil; Paolo De Coppi; Roberto Vettor
Abstract Satellite cells (SCs) are undifferentiated skeletal muscle cells that allow muscular growth and regeneration. Since their first description, SCs were simply considered myogenic precursors, but now it is widely accepted that SCs are a heterogeneous stem cell population characterized by plasticity and self-renewal. In this report we focus on SCs capacity to undergo adipogenic differentiation both spontaneous and induced by adipogenic factors. Understanding SC behavior is especially important because their adipogenic potential could represent a pathophysiological explanation for the intramuscular fat depots and associated insulin resistance that characterize many metabolic diseases and age-related sarcopenia. Moreover, SC are a therapeutic promise for neuromuscular diseases in the context of tissue engineering, representing an interesting cell source for implantation.
Endocrine Reviews | 2002
Corrado Betterle; Chiara Dal Pra; Franco Mantero; R. Zanchetta
The Journal of Clinical Endocrinology and Metabolism | 2006
Graziella Coco; Chiara Dal Pra; Fabio Presotto; Maria Paola Albergoni; Cristina Canova; B. Pedini; R. Zanchetta; Shu Chen; Jadwiga Furmaniak; Bernard Rees Smith; Franco Mantero; Corrado Betterle
Thyroid | 2006
Nobuhiro Nakatake; Jane Sanders; Tonya Richards; Peter Burne; Carol Barrett; Chiara Dal Pra; Fabio Presotto; Corrado Betterle; Jadwiga Furmaniak; Bernard Rees Smith
International Journal of Molecular Medicine | 2008
Sara Romano; Gabriella Milan; Caterina Veronese; Gayle B. Collin; Jan D. Marshall; Cinzia Centobene; Francesca Favaretto; Chiara Dal Pra; Alessandro Scarda; Sonia Leandri; Jürgen K. Naggert; Pietro Maffei; Roberto Vettor
Obesity Surgery | 2017
Anna Belligoli; Marta Sanna; Roberto Serra; Roberto Fabris; Chiara Dal Pra; Scilla Conci; Paola Fioretto; Luca Prevedello; Mirto Foletto; Roberto Vettor; Luca Busetto
Obesity Surgery | 2018
Silvia Bettini; Emanuel Bordigato; Roberto Fabris; Roberto Serra; Chiara Dal Pra; Anna Belligoli; Marta Sanna; Chiara Compagnin; Mirto Foletto; Luca Prevedello; Paola Fioretto; Roberto Vettor; Luca Busetto